BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25266548)

  • 1. Genetic liability for schizophrenia predicts risk of immune disorders.
    Stringer S; Kahn RS; de Witte LD; Ophoff RA; Derks EM
    Schizophr Res; 2014 Nov; 159(2-3):347-52. PubMed ID: 25266548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
    Cross-Disorder Group of the Psychiatric Genomics Consortium
    Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia.
    Hartz SM; Horton AC; Oehlert M; Carey CE; Agrawal A; Bogdan R; Chen LS; Hancock DB; Johnson EO; Pato CN; Pato MT; Rice JP; Bierut LJ
    Biol Psychiatry; 2017 Nov; 82(10):709-715. PubMed ID: 28739213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.
    Pouget JG; ; Han B; Wu Y; Mignot E; Ollila HM; Barker J; Spain S; Dand N; Trembath R; Martin J; Mayes MD; Bossini-Castillo L; López-Isac E; Jin Y; Santorico SA; Spritz RA; Hakonarson H; Polychronakos C; Raychaudhuri S; Knight J
    Hum Mol Genet; 2019 Oct; 28(20):3498-3513. PubMed ID: 31211845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.
    Bigdeli TB; Ripke S; Bacanu SA; Lee SH; Wray NR; Gejman PV; Rietschel M; Cichon S; St Clair D; Corvin A; Kirov G; McQuillin A; Gurling H; Rujescu D; Andreassen OA; Werge T; Blackwood DH; Pato CN; Pato MT; Malhotra AK; O'Donovan MC; Kendler KS; Fanous AH;
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):276-89. PubMed ID: 26663532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS.
    Wang Q; Yang C; Gelernter J; Zhao H
    Hum Genet; 2015 Nov; 134(11-12):1195-209. PubMed ID: 26340901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis.
    Agerbo E; Sullivan PF; Vilhjálmsson BJ; Pedersen CB; Mors O; Børglum AD; Hougaard DM; Hollegaard MV; Meier S; Mattheisen M; Ripke S; Wray NR; Mortensen PB
    JAMA Psychiatry; 2015 Jul; 72(7):635-41. PubMed ID: 25830477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.
    Calafato MS; Thygesen JH; Ranlund S; Zartaloudi E; Cahn W; Crespo-Facorro B; Díez-Revuelta Á; Di Forti M; ; Hall MH; Iyegbe C; Jablensky A; Kahn R; Kalaydjieva L; Kravariti E; Lin K; McDonald C; McIntosh AM; McQuillin A; Picchioni M; Rujescu D; Shaikh M; Toulopoulou T; Os JV; Vassos E; Walshe M; Powell J; Lewis CM; Murray RM; Bramon E
    Br J Psychiatry; 2018 Sep; 213(3):535-541. PubMed ID: 30113282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.
    Mullins N; Perroud N; Uher R; Butler AW; Cohen-Woods S; Rivera M; Malki K; Euesden J; Power RA; Tansey KE; Jones L; Jones I; Craddock N; Owen MJ; Korszun A; Gill M; Mors O; Preisig M; Maier W; Rietschel M; Rice JP; Müller-Myhsok B; Binder EB; Lucae S; Ising M; Craig IW; Farmer AE; McGuffin P; Breen G; Lewis CM
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jul; 165B(5):428-37. PubMed ID: 24964207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation.
    ; ; Bramon E; Pirinen M; Strange A; Lin K; Freeman C; Bellenguez C; Su Z; Band G; Pearson R; Vukcevic D; Langford C; Deloukas P; Hunt S; Gray E; Dronov S; Potter SC; Tashakkori-Ghanbaria A; Edkins S; Bumpstead SJ; Arranz MJ; Bakker S; Bender S; Bruggeman R; Cahn W; Chandler D; Collier DA; Crespo-Facorro B; Dazzan P; de Haan L; Di Forti M; Dragović M; Giegling I; Hall J; Iyegbe C; Jablensky A; Kahn RS; Kalaydjieva L; Kravariti E; Lawrie S; Linszen DH; Mata I; McDonald C; McIntosh A; Myin-Germeys I; Ophoff RA; Pariante CM; Paunio T; Picchioni M; ; Ripke S; Rujescu D; Sauer H; Shaikh M; Sussmann J; Suvisaari J; Tosato S; Toulopoulou T; Van Os J; Walshe M; Weisbrod M; Whalley H; Wiersma D; Blackwell JM; Brown MA; Casas JP; Corvin A; Duncanson A; Jankowski JA; Markus HS; Mathew CG; Palmer CN; Plomin R; Rautanen A; Sawcer SJ; Trembath RC; Wood NW; Barroso I; Peltonen L; Lewis CM; Murray RM; Donnelly P; Powell J; Spencer CC
    Biol Psychiatry; 2014 Mar; 75(5):386-97. PubMed ID: 23871474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis.
    Derks EM; Vorstman JA; Ripke S; Kahn RS; ; Ophoff RA
    PLoS One; 2012; 7(6):e37852. PubMed ID: 22761660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia.
    Costas J; Carrera N; Alonso P; Gurriarán X; Segalàs C; Real E; López-Solà C; Mas S; Gassó P; Domènech L; Morell M; Quintela I; Lázaro L; Menchón JM; Estivill X; Carracedo Á
    Transl Psychiatry; 2016 Mar; 6(3):e768. PubMed ID: 27023174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular validation of the schizophrenia spectrum.
    Bigdeli TB; Bacanu SA; Webb BT; Walsh D; O'Neill FA; Fanous AH; Riley BP; Kendler KS
    Schizophr Bull; 2014 Jan; 40(1):60-5. PubMed ID: 23970557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.
    Prins BP; Abbasi A; Wong A; Vaez A; Nolte I; Franceschini N; Stuart PE; Guterriez Achury J; Mistry V; Bradfield JP; Valdes AM; Bras J; Shatunov A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Lu C; Han B; Raychaudhuri S; Bevan S; Mayes MD; Tsoi LC; Evangelou E; Nair RP; Grant SF; Polychronakos C; Radstake TR; van Heel DA; Dunstan ML; Wood NW; Al-Chalabi A; Dehghan A; Hakonarson H; Markus HS; Elder JT; Knight J; Arking DE; Spector TD; Koeleman BP; van Duijn CM; Martin J; Morris AP; Weersma RK; Wijmenga C; Munroe PB; Perry JR; Pouget JG; Jamshidi Y; Snieder H; Alizadeh BZ
    PLoS Med; 2016 Jun; 13(6):e1001976. PubMed ID: 27327646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms.
    Fanous AH; Zhou B; Aggen SH; Bergen SE; Amdur RL; Duan J; Sanders AR; Shi J; Mowry BJ; Olincy A; Amin F; Cloninger CR; Silverman JM; Buccola NG; Byerley WF; Black DW; Freedman R; Dudbridge F; Holmans PA; Ripke S; Gejman PV; Kendler KS; Levinson DF;
    Am J Psychiatry; 2012 Dec; 169(12):1309-17. PubMed ID: 23212062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic associations of neurodevelopmental genes in suicide attempt.
    Sokolowski M; Wasserman J; Wasserman D
    Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study.
    Pillinger T; Osimo EF; de Marvao A; Shah M; Francis C; Huang J; D'Ambrosio E; Firth J; Nour MM; McCutcheon RA; Pardiñas AF; Matthews PM; O'Regan DP; Howes OD
    Lancet Psychiatry; 2023 Feb; 10(2):98-107. PubMed ID: 36632818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting Schizophrenia Genetics by Utilizing Genetic Overlap With Brain Morphology.
    van der Meer D; Shadrin AA; O'Connell K; Bettella F; Djurovic S; Wolfers T; Alnæs D; Agartz I; Smeland OB; Melle I; Sánchez JM; Linden DEJ; Dale AM; Westlye LT; Andreassen OA; Frei O; Kaufmann T
    Biol Psychiatry; 2022 Aug; 92(4):291-298. PubMed ID: 35164939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data mining approaches for genome-wide association of mood disorders.
    Pirooznia M; Seifuddin F; Judy J; Mahon PB; ; Potash JB; Zandi PP
    Psychiatr Genet; 2012 Apr; 22(2):55-61. PubMed ID: 22081063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia.
    Wang SH; Hsiao PC; Yeh LL; Liu CM; Liu CC; Hwang TJ; Hsieh MH; Chien YL; Lin YT; Chandler SD; Faraone SV; Laird N; Neale B; McCarroll SA; Glatt SJ; Tsuang MT; Hwu HG; Chen WJ
    Genes Brain Behav; 2018 Jan; 17(1):49-55. PubMed ID: 28719030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.